MY
Masanori Yagi

Publications (2)

Safety and immunogenicity of BK-SE36 in a blinded, randomized, controlled, age de-escalating phase Ib clinical trial in Burkinabe children
Article scientifique · 2022
Antibody titres and boosting after natural malaria infection in BK-SE36 vaccine responders during a follow-up study in Uganda
Article scientifique · 2016

Domaines principaux

Sciences de la santé2

Statistiques

Consultations3
Téléchargements0